Pharma’s $1 Trillion ‘Firepower’ Hangs Over Biotech Stocks in Limbo

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 50%

Business News News

Business Business Latest News,Business Business Headlines

A flurry of deals at the start of the year sparked optimism for a biotech stock resurgence but a swing in sentiment at the direction of interest rates has left the sector hanging on tenterhooks.

Korea Oil and Gas Shares Jump After Offshore Fuel DiscoveryGill’s Purported GameStop Options Would Net Him $170 MillionItaly’s Giorgetti Is in Frame as Meloni Reset Speculation MountsFive Key Charts to Watch in Global Commodity Markets This WeekGerman Minister Expects ECB Rate Cut Soon, Hopes More FollowChinese Developer Poly Mulls $1.

2 Billion AI Bet on Swedish Data CentersRed tape and delays are holding back Canada’s productivity, Poloz and Manley sayStatistics Canada says economy grew at 1.7% annualized rate in Q1Summer interest rate cut could prompt rebound in consumer spending: expertsThe Daily Chase: Bank earnings season continues as National, BMO hike dividendsThe Daily Chase: GameStop shares popping againRetail sales climb 0.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stock market today: Wall Street hangs around its records after Dow briefly tops 40,000NEW YORK (AP) — U.S. stocks drifted to a mixed close near their record levels after the Dow Jones Industrial Average briefly topped the 40,000 level for the first time. The Dow ended with a loss of 0.1% Thursday.
Source: SooToday - 🏆 8. / 85 Read more »